Please use this identifier to cite or link to this item: https://repositorio.ufba.br/handle/ri/7821
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSpinardi-Barbisan, Ana Lúcia Tozzi-
dc.contributor.authorKaneno, Ramon-
dc.contributor.authorRodrigues, Maria Aparecida Marchesan-
dc.contributor.authorSalvadori, Daisy Maria Fávero-
dc.contributor.authorMoreira, Eduardo Luiz Trindade-
dc.contributor.authorBarbisan, Luís Fernando-
dc.contributor.authorCamargo, João Lauro Viana de-
dc.creatorSpinardi-Barbisan, Ana Lúcia Tozzi-
dc.creatorKaneno, Ramon-
dc.creatorRodrigues, Maria Aparecida Marchesan-
dc.creatorSalvadori, Daisy Maria Fávero-
dc.creatorMoreira, Eduardo Luiz Trindade-
dc.creatorBarbisan, Luís Fernando-
dc.creatorCamargo, João Lauro Viana de-
dc.date.accessioned2013-01-11T15:44:46Z-
dc.date.issued2000-
dc.identifier.issn0304-3835-
dc.identifier.urihttp://www.repositorio.ufba.br/ri/handle/ri/7821-
dc.descriptionTexto completo: acesso restrito. p.121–129pt_BR
dc.description.abstractThe lymphoproliferative response and T lymphocyte subsets were evaluated at different stages of carcinogenesis in male Wistar rats sequentially initiated with N-diethylnitrosamine (DEN), N-butyl-N-4(hydroxybutyl)nitrosamine (BBN), N-methyl-N-nitrosourea (MNU), dihydroxy-di-N-propylnitrosamine (DHPN) and N,N′-dimethylhydrazine (DMH) (DMBDD initiation). One group was evaluated at the 4th week and other initiated group at the 30th week. Two initiated groups were also exposed through diet to 2-acetylaminofluorene (2-AAF) or phenobarbital (PB), from the 6th until the 30th week. Two groups received only 2-AAF or PB until the 30th week. Five groups were studied to evaluate the effects of each initiator. The lymphoproliferative response was induced in vitro by concanavalin A and the percentage of T lymphocyte subsets was determined by flow cytometry. All groups submitted to initiation only, initiation plus promotion, or promotion only, developed significantly more preneoplastic lesions than the untreated control group. The main target organs for tumor development were the liver, colon, urinary bladder, kidneys and Zymbal glands, mainly in the group treated with DMBDD+2-AAF. There were no alterations of the lymphoproliferative response and of the T lymphocyte subsets percentage in the DMBDD-treated group at the 4th and 30th weeks. At the 30th week, the T lymphocyte subsets percentage was also not affected in the initiated groups after treatments with 2-AAF or PB. The lymphoproliferative response, however, was decreased in the DMBDD+2-AAF group and in the groups treated only with 2-AAF or PB. The present results indicate that the initiating chemicals used in the DMBDD initiation protocol do not exert any influence on the immune system. The alteration of lymphoproliferative response induced at the advanced stage of carcinogenesis without alteration of T lymphocyte subsets may indicate that the influence of 2-AAF and PB on the immune system is functional and not toxic.pt_BR
dc.language.isoenpt_BR
dc.sourcehttp://dx.doi.org/10.1016/S0304-3835(00)00344-Xpt_BR
dc.subjectLymphoproliferative responsept_BR
dc.subjectLymphocyte subsetspt_BR
dc.subjectFlow cytometrypt_BR
dc.subjectCancerpt_BR
dc.subjectMulti-organ carcinogenesispt_BR
dc.subjectChemical carcinogenspt_BR
dc.titleLymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar ratspt_BR
dc.title.alternativeCancer Letterspt_BR
dc.typeArtigo de Periódicopt_BR
dc.identifier.numberv. 154, n. 2pt_BR
dc.embargo.liftdate10000-01-01-
Appears in Collections:Artigo Publicado em Periódico (EMV)

Files in This Item:
File Description SizeFormat 
Kanero.pdf
  Restricted Access
213,27 kBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.